{"id":"https://openalex.org/W2921591566","doi":"https://doi.org/10.1117/12.2513001","title":"A combination of intra- and peritumoral features on baseline CT scans is associated with overall survival in non-small cell lung cancer patients treated with immune checkpoint inhibitors: a multi-agent multi-site study","display_name":"A combination of intra- and peritumoral features on baseline CT scans is associated with overall survival in non-small cell lung cancer patients treated with immune checkpoint inhibitors: a multi-agent multi-site study","publication_year":2019,"publication_date":"2019-03-13","ids":{"openalex":"https://openalex.org/W2921591566","doi":"https://doi.org/10.1117/12.2513001","mag":"2921591566"},"language":"en","primary_location":{"id":"doi:10.1117/12.2513001","is_oa":false,"landing_page_url":"https://doi.org/10.1117/12.2513001","pdf_url":null,"source":{"id":"https://openalex.org/S4306519510","display_name":"Medical Imaging 2019: Computer-Aided Diagnosis","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":true,"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Medical Imaging 2019: Computer-Aided Diagnosis","raw_type":"proceedings-article"},"type":"article","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5033238361","display_name":"Pradnya D. Patil","orcid":"https://orcid.org/0000-0003-1304-3678"},"institutions":[{"id":"https://openalex.org/I1316902750","display_name":"Cleveland Clinic","ror":"https://ror.org/03xjacd83","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1316902750"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Pradnya Patil","raw_affiliation_strings":["Cleveland Clinic Foundation (United States)"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cleveland Clinic Foundation (United States)","institution_ids":["https://openalex.org/I1316902750"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5088228366","display_name":"Kaustav Bera","orcid":"https://orcid.org/0000-0001-9831-6000"},"institutions":[{"id":"https://openalex.org/I58956616","display_name":"Case Western Reserve University","ror":"https://ror.org/051fd9666","country_code":"US","type":"education","lineage":["https://openalex.org/I58956616"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Kaustav Bera","raw_affiliation_strings":["Case Western Reserve Univ. (United States)"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Case Western Reserve Univ. (United States)","institution_ids":["https://openalex.org/I58956616"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5038456571","display_name":"Pirya Velu","orcid":null},"institutions":[{"id":"https://openalex.org/I36788626","display_name":"California University of Pennsylvania","ror":"https://ror.org/01spssf70","country_code":"US","type":"education","lineage":["https://openalex.org/I36788626"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Pirya Velu","raw_affiliation_strings":["Univ. of Pennsylvania  (United States)"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Univ. of Pennsylvania  (United States)","institution_ids":["https://openalex.org/I36788626"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5035645374","display_name":"Mohammadhadi Khorrami","orcid":"https://orcid.org/0000-0002-4141-8548"},"institutions":[{"id":"https://openalex.org/I58956616","display_name":"Case Western Reserve University","ror":"https://ror.org/051fd9666","country_code":"US","type":"education","lineage":["https://openalex.org/I58956616"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Mohammadhadi Khorrami","raw_affiliation_strings":["Case Western Reserve Univ. (United States)"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Case Western Reserve Univ. (United States)","institution_ids":["https://openalex.org/I58956616"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5036343196","display_name":"Prateek Prasanna","orcid":"https://orcid.org/0000-0002-3068-3573"},"institutions":[{"id":"https://openalex.org/I58956616","display_name":"Case Western Reserve University","ror":"https://ror.org/051fd9666","country_code":"US","type":"education","lineage":["https://openalex.org/I58956616"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Prateek Prasanna","raw_affiliation_strings":["Case Western Reserve Univ. (United States)"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Case Western Reserve Univ. (United States)","institution_ids":["https://openalex.org/I58956616"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5066861614","display_name":"Vamsidhar Velcheti","orcid":"https://orcid.org/0000-0002-6589-0759"},"institutions":[{"id":"https://openalex.org/I1316902750","display_name":"Cleveland Clinic","ror":"https://ror.org/03xjacd83","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1316902750"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Vamsidhar Velcheti","raw_affiliation_strings":["Cleveland Clinic Foundation (United States)","NYU Langone (United States)"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cleveland Clinic Foundation (United States)","institution_ids":["https://openalex.org/I1316902750"]},{"raw_affiliation_string":"NYU Langone (United States)","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5027642699","display_name":"Anant Madabhushi","orcid":"https://orcid.org/0000-0002-5741-0399"},"institutions":[{"id":"https://openalex.org/I4210110978","display_name":"Louis Stokes Cleveland VA Medical Center","ror":"https://ror.org/01vrybr67","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1322918889","https://openalex.org/I2799886695","https://openalex.org/I4210110978","https://openalex.org/I4210127612"]},{"id":"https://openalex.org/I58956616","display_name":"Case Western Reserve University","ror":"https://ror.org/051fd9666","country_code":"US","type":"education","lineage":["https://openalex.org/I58956616"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Anant Madabhushi","raw_affiliation_strings":["Case Western Reserve Univ. (United States)","Louis Stokes Cleveland Veterans Administration Medical Ctr.  (United States)"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Case Western Reserve Univ. (United States)","institution_ids":["https://openalex.org/I58956616"]},{"raw_affiliation_string":"Louis Stokes Cleveland Veterans Administration Medical Ctr.  (United States)","institution_ids":["https://openalex.org/I4210110978"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5107993151","display_name":"Mehdi Alilou","orcid":"https://orcid.org/0000-0002-0119-7322"},"institutions":[{"id":"https://openalex.org/I58956616","display_name":"Case Western Reserve University","ror":"https://ror.org/051fd9666","country_code":"US","type":"education","lineage":["https://openalex.org/I58956616"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Mehdi Alilou","raw_affiliation_strings":["Case Western Reserve Univ. (United States)"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Case Western Reserve Univ. (United States)","institution_ids":["https://openalex.org/I58956616"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5059061070","display_name":"Pingfu Fu","orcid":"https://orcid.org/0000-0002-2334-5218"},"institutions":[{"id":"https://openalex.org/I58956616","display_name":"Case Western Reserve University","ror":"https://ror.org/051fd9666","country_code":"US","type":"education","lineage":["https://openalex.org/I58956616"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Pingfu Fu","raw_affiliation_strings":["Case Western Reserve Univ. (United States)"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Case Western Reserve Univ. (United States)","institution_ids":["https://openalex.org/I58956616"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":9,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":1.406,"has_fulltext":false,"cited_by_count":11,"citation_normalized_percentile":{"value":0.81377486,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":89,"max":97},"biblio":{"volume":null,"issue":null,"first_page":"26","last_page":"26"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T12422","display_name":"Radiomics and Machine Learning in Medical Imaging","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2741","display_name":"Radiology, Nuclear Medicine and Imaging"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T12422","display_name":"Radiomics and Machine Learning in Medical Imaging","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2741","display_name":"Radiology, Nuclear Medicine and Imaging"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.9965000152587891,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10202","display_name":"Lung Cancer Diagnosis and Treatment","score":0.9958000183105469,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/atezolizumab","display_name":"Atezolizumab","score":0.8744668960571289},{"id":"https://openalex.org/keywords/pembrolizumab","display_name":"Pembrolizumab","score":0.8629368543624878},{"id":"https://openalex.org/keywords/nivolumab","display_name":"Nivolumab","score":0.8566704392433167},{"id":"https://openalex.org/keywords/medicine","display_name":"Medicine","score":0.8290552496910095},{"id":"https://openalex.org/keywords/durvalumab","display_name":"Durvalumab","score":0.6648368239402771},{"id":"https://openalex.org/keywords/oncology","display_name":"Oncology","score":0.6147974133491516},{"id":"https://openalex.org/keywords/immunotherapy","display_name":"Immunotherapy","score":0.6084942817687988},{"id":"https://openalex.org/keywords/lung-cancer","display_name":"Lung cancer","score":0.564195990562439},{"id":"https://openalex.org/keywords/internal-medicine","display_name":"Internal medicine","score":0.5121936202049255},{"id":"https://openalex.org/keywords/response-evaluation-criteria-in-solid-tumors","display_name":"Response Evaluation Criteria in Solid Tumors","score":0.5098609328269958},{"id":"https://openalex.org/keywords/clinical-trial","display_name":"Clinical trial","score":0.47282469272613525},{"id":"https://openalex.org/keywords/immune-checkpoint","display_name":"Immune checkpoint","score":0.45457005500793457},{"id":"https://openalex.org/keywords/neuroendocrine-tumors","display_name":"Neuroendocrine tumors","score":0.45211824774742126},{"id":"https://openalex.org/keywords/cancer","display_name":"Cancer","score":0.4461438059806824},{"id":"https://openalex.org/keywords/biomarker","display_name":"Biomarker","score":0.43597212433815},{"id":"https://openalex.org/keywords/phases-of-clinical-research","display_name":"Phases of clinical research","score":0.23251071572303772}],"concepts":[{"id":"https://openalex.org/C2775949291","wikidata":"https://www.wikidata.org/wiki/Q20707748","display_name":"Atezolizumab","level":5,"score":0.8744668960571289},{"id":"https://openalex.org/C2780057760","wikidata":"https://www.wikidata.org/wiki/Q13896859","display_name":"Pembrolizumab","level":4,"score":0.8629368543624878},{"id":"https://openalex.org/C2780030458","wikidata":"https://www.wikidata.org/wiki/Q7041828","display_name":"Nivolumab","level":4,"score":0.8566704392433167},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8290552496910095},{"id":"https://openalex.org/C2777742743","wikidata":"https://www.wikidata.org/wiki/Q19904005","display_name":"Durvalumab","level":5,"score":0.6648368239402771},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.6147974133491516},{"id":"https://openalex.org/C2777701055","wikidata":"https://www.wikidata.org/wiki/Q1427096","display_name":"Immunotherapy","level":3,"score":0.6084942817687988},{"id":"https://openalex.org/C2776256026","wikidata":"https://www.wikidata.org/wiki/Q47912","display_name":"Lung cancer","level":2,"score":0.564195990562439},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5121936202049255},{"id":"https://openalex.org/C2779984678","wikidata":"https://www.wikidata.org/wiki/Q2145898","display_name":"Response Evaluation Criteria in Solid Tumors","level":4,"score":0.5098609328269958},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.47282469272613525},{"id":"https://openalex.org/C2780851360","wikidata":"https://www.wikidata.org/wiki/Q21686041","display_name":"Immune checkpoint","level":4,"score":0.45457005500793457},{"id":"https://openalex.org/C2779066768","wikidata":"https://www.wikidata.org/wiki/Q1981276","display_name":"Neuroendocrine tumors","level":2,"score":0.45211824774742126},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.4461438059806824},{"id":"https://openalex.org/C2781197716","wikidata":"https://www.wikidata.org/wiki/Q864574","display_name":"Biomarker","level":2,"score":0.43597212433815},{"id":"https://openalex.org/C31760486","wikidata":"https://www.wikidata.org/wiki/Q7180990","display_name":"Phases of clinical research","level":3,"score":0.23251071572303772},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.0},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1117/12.2513001","is_oa":false,"landing_page_url":"https://doi.org/10.1117/12.2513001","pdf_url":null,"source":{"id":"https://openalex.org/S4306519510","display_name":"Medical Imaging 2019: Computer-Aided Diagnosis","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":true,"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Medical Imaging 2019: Computer-Aided Diagnosis","raw_type":"proceedings-article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.8500000238418579,"display_name":"Good health and well-being"}],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":30,"referenced_works":["https://openalex.org/W1974176583","https://openalex.org/W1985528986","https://openalex.org/W2005992530","https://openalex.org/W2019607817","https://openalex.org/W2022465587","https://openalex.org/W2036382630","https://openalex.org/W2039123767","https://openalex.org/W2066671159","https://openalex.org/W2067959276","https://openalex.org/W2105283525","https://openalex.org/W2120431466","https://openalex.org/W2126901657","https://openalex.org/W2128739912","https://openalex.org/W2133650808","https://openalex.org/W2410864298","https://openalex.org/W2530038065","https://openalex.org/W2554618897","https://openalex.org/W2570912166","https://openalex.org/W2735874307","https://openalex.org/W2786052636","https://openalex.org/W2800038717","https://openalex.org/W2806575069","https://openalex.org/W2895880339","https://openalex.org/W2904258904","https://openalex.org/W2924086752","https://openalex.org/W4236256952","https://openalex.org/W4249999102","https://openalex.org/W4250026084","https://openalex.org/W6757167275","https://openalex.org/W6760823045"],"related_works":["https://openalex.org/W4400043472","https://openalex.org/W4386284132","https://openalex.org/W3210901691","https://openalex.org/W4401209747","https://openalex.org/W2982865941","https://openalex.org/W4392100959","https://openalex.org/W3017309209","https://openalex.org/W4206430965","https://openalex.org/W2969038597","https://openalex.org/W2981548200"],"abstract_inverted_index":{"Immune":[0],"checkpoint":[1,42,200,364],"inhibitors":[2,365],"targeting":[3],"the":[4,83,111,131,190,217,231,253,256,266,289,299,313],"programmed":[5],"cell":[6,21,370],"death":[7],"(PD)1/":[8],"L1":[9],"axis":[10],"have":[11,63],"been":[12,194],"approved":[13],"for":[14,25,51,366],"treatment":[15],"of":[16,85,130,184,199,255,358],"chemotherapy":[17],"refractory":[18],"advanced":[19],"non-small":[20,369],"lung":[22,371],"cancer":[23],"(NSCLC)":[24],"a":[26,47,100,160,234,249,355],"few":[27],"years.":[28],"While":[29],"higher":[30],"PD-L1":[31,61],"expression":[32,62],"is":[33,45,107],"associated":[34,138,294],"with":[35,40,59,92,139,150,196,259,295,368],"better":[36],"outcomes":[37],"after":[38],"monotherapy":[39],"immune":[41],"inhibitors,":[43],"it":[44],"not":[46],"perfect":[48],"predictive":[49],"biomarker":[50],"clinical":[52,67],"benefit":[53,84],"from":[54,95,125,133,152,166,176,182,212,222],"immunotherapy,":[55],"because":[56],"some":[57,89],"patients":[58,90,147,367],"low":[60],"sustained":[64],"responses.":[65],"In":[66,113,272],"practice,":[68],"using":[69,241],"radiological":[70],"tools":[71],"like":[72],"Response":[73],"Evaluation":[74],"Criteria":[75],"in":[76,104,144,189,265,298],"Solid":[77],"Tumors":[78],"(RECIST),":[79],"tends":[80],"to":[81,109,118,346,363],"underestimate":[82],"therapy.":[86],"For":[87],"instance,":[88],"treated":[91,149,195],"immunotherapy":[93],"suffer":[94],"pseudoprogression":[96],"while":[97],"actually":[98],"having":[99],"favorable":[101],"response,":[102],"RECIST":[103],"this":[105,114],"setting":[106],"inadequate":[108],"capture":[110],"response.":[112],"study":[115],"we":[116],"sought":[117],"explore":[119],"whether":[120],"radiomic":[121,209,235,257,350],"texture":[122,210],"features":[123,211],"extracted":[124,221],"both":[126,297],"inside":[127],"and":[128,169,206,215,245,268,278,312,360],"outside":[129,216],"tumor":[132,218],"baseline":[134,223],"CT":[135,225],"scans":[136],"were":[137,157,220,283],"overall":[140,260],"patient":[141],"survival":[142,261],"(OS)":[143,262],"139":[145],"NSCLC":[146],"being":[148],"IO":[151],"two":[153,170,269,314],"separate":[154],"sites.":[155],"Patients":[156,188],"divided":[158],"into":[159],"discovery":[161,232,267,300],"(<i>D</i><sub>1</sub>":[162],"=":[163,174,180,303,306,320,324,328,332,336,340],"50;":[164],"nivolumab":[165],"Cleveland":[167,177],"Clinic)":[168],"validation":[171,191,270,315],"sets":[172,192,317],"(<i>D</i><sub>2</sub>":[173],"62":[175],"Clinic,":[178],"<i>D</i><sub>3</sub>":[179],"27":[181],"University":[183],"Pennsylvania":[185],"Health":[186],"System.":[187],"had":[193],"different":[197],"types":[198],"inhibitor":[201],"drugs":[202],"including":[203],"nivolumab,":[204],"pembrolizumab,":[205],"atezolizumab.":[207],"454":[208],"within":[213],"(intra-tumoral)":[214],"(peri-tumoral)":[219],"contrast":[224],"images.":[226],"Following":[227],"feature":[228],"selection":[229,246],"on":[230],"set,":[233],"risk-score":[236],"signature":[237,258,291,351],"was":[238,263,292],"generated":[239],"by":[240],"least":[242],"absolute":[243],"shrinkage":[244],"operator.":[247],"Using":[248],"Cox":[250],"regression":[251],"model,":[252],"association":[254],"evaluated":[264],"sets.":[271],"addition,":[273],"95%":[274,322,334],"confidence":[275],"intervals":[276],"(CI)":[277],"relative":[279],"hazard":[280],"ratios":[281],"(HR)":[282],"calculated.":[284],"Our":[285,342],"results":[286,344],"revealed":[287],"that":[288,348],"radiomics":[290],"significantly":[293],"OS,":[296],"set":[301],"(HR":[302],"5.06,":[304],"95%CI":[305],"3,":[307],"8.55;":[308],"p-value":[309,327,339],"&lt;":[310],"0.0001)":[311],"data":[316],"(<i>D</i><sub>2</sub>:":[318],"HR":[319,331],"5.88,":[321],"CI":[323,335],"2.19,":[325],"21.63,":[326],"0.0009;":[329],"<i>D</i><sub>3</sub>:":[330],"5.37,":[333],"1.74,":[337],"16.57,":[338],"0.0034).":[341],"initial":[343],"appear":[345],"suggest":[347],"our":[349],"could":[352],"serve":[353],"as":[354],"non-invasive":[356],"way":[357],"predicting":[359],"monitoring":[361],"response":[362],"cancer.":[372]},"counts_by_year":[{"year":2023,"cited_by_count":3},{"year":2022,"cited_by_count":2},{"year":2021,"cited_by_count":3},{"year":2020,"cited_by_count":1},{"year":2019,"cited_by_count":2}],"updated_date":"2026-06-11T09:08:48.828518","created_date":"2025-10-10T00:00:00"}